Skip to Content

Case Study

120-Subject, Procedure-Intensive TQT Study Executed Efficiently, With High-Quality Results

A leading global pharmaceutical company awarded an intricate TQT trial to Spaulding Clinical with strict inclusion/ exclusion criteria. These criteria included the need for female subjects of non-child-bearing potential, all subjects with the absence of suicide-ideation behavior, TQT ECG time points in close succession to PK and vital-sign collection, as well as the need to include experimental PK collection procedures using two (2) new/dried blood spot techniques.


Back to Resources

Ready to partner with Spaulding Clinical for your Phase I study?

Let’s Talk